Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Clinical trial NCT07133308 · RECRUITING
Trial details
- NCT number
- NCT07133308
- Sponsor
- Sun Pharmaceutical Industries, Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-05
- Primary completion
- 2028-05-01
- Enrollment
- 355
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.